SETDB1 and acute myeloid leukemia: On the contrary, SETDB1 inhibits the expression of genes associated with acute myeloid leukemia (AML), such as Dock1, Hoxa9, and Six1, to delay MLL-AF9-mediated disease progression by promoting the differentiation of leukemia cells [104].